Back to Results
| First Page | Meta Content | |
|---|---|---|
 | Open DocumentFile Size: 900,35 KBShare Result on FacebookCityPhiladelphia / /CompanySigma-Aldrich / GE / Invitrogen Inc. / /CountryUnited States / / /EventProduct Issues / /FacilityHoward Hughes Medical Institute / Osaka University / University of Pennsylvania Medical Center / University of Pennsylvania / /IndustryTermmacrophage product / therapy for CF disease / therapy for CF lung disease / predominant site / respiratory and digestive systems / therapy for cystic fibrosis / chemical reduction / phosphate buffer solution / digestive and respiratory systems / /MedicalConditioninflammatory enzyme myeloperoxidase / MPO-produced injuries / progressive / destructive intraluminal inflammation / ystic fibrosis / Lower airway inflammation / cases inflammation / chronic irritation / HAE / chronic insidious injuries / Airway inflammation / CF lung illness / Pulmonary / excessive inflammation / slow disease / subtotal myeloperoxidase deficiency / Lung injuries / pulmonary inflammation / severe lung injuries / severe injuries / cystic fibrosis / MPO-caused cell injuries / cardiovascular diseases / inflammatory diseases / clinical infection / lung cancers / mouse neuroblastoma cell line / asthma / coronary artery stenosis / common fatal hereditary disease / atherosclerosis / cystic fibrosis lung disease / CF disease / MPO-caused injuries / severe cell injuries / peripheral insulin resistance / diabetes / cardiovascular disease / CF-lung illness / congenital MPO deficiency / certain cancers / Primary inflammation / lung cancer / Pulmonary dysfunction / lung illness / Diabetes mellitus / Parkinson’s disease / diseases / lung infection / pleiotropic disease / coronary artery disease / previously reported lung cell injuries / infection / airway disease / beta-cell dysfunction / thrombus / neurodegenerative diseases / deficiency / inflammation / CF lung disease / bactericidal and inflammatory agents / H2O2-caused injuries / inflammatory / injuries / /NaturalFeatureAshby MT / /OrganizationUniversity of Pennsylvania / University of Pennsylvania Medical Center / Osaka University / Zhe Lu1 Department of Physiology / Cystic Fibrosis Foundation / Howard Hughes Medical Institute / /PersonVan Der Vliet / Yanping Xu / T. Hoshi / /Positioninvestigator / appreciated mediator / reactive Author / Quinton PM / /Productbalanced salt / Ibuprofen / M-16 / OCl / CFTR / CFTR channels / CFTR gene / protection / /ProvinceOrStatePennsylvania / /TechnologyCloning / apoptosis / drug development / /URLwww.pnas.org͞cgi͞doi͞10.1073͞pnas.0911412106 / /SocialTag |